Stenting System Helps Treat Blocked Neck Arteries
By HospiMedica International staff writers Posted on 10 Apr 2016 |

Image: The Enroute NeuroProtection System (NPS) (Photo courtesy of Silk Road Medical).
A novel system designed specifically for transcarotid artery revascularization (TCAR) helps prevent stroke in patients with carotid artery disease.
The Enroute NeuroProtection System (NPS) is designed to enable the insertion of a stent directly into the carotid artery in the neck, instead of using a percutaneous route through the groin and up the femoral artery, reducing the surgical risks and potential complications associated with more invasive procedures. In addition to TCAR access, the procedure also protects the brain during the intervention via flow reversal, a mechanism that redirects blood flow away from the brain so that it can carry any debris created to an external filter.
This high rate temporary blood flow reversal is important to help protect the brain from stroke while surgeons subsequently deliver the Enroute Transcarotid Stent (TNS), a self-expanding stent made of nickel-titanium (nitinol) alloy tubing, which is laser-cut into a mesh shape that opens automatically over the blockage. The Enroute NPS and TNS are products of Silk Road Medical (Sunnyvale, CA, USA), and have been approved by the US Food and Drug Administration (FDA).
“Whereas elsewhere in the body we routinely use minimally invasive endovascular techniques to treat vascular disorders, carotid artery disease is one of the last frontiers that is still treated primarily by an invasive surgical approach,” said Professor Ralf Kolvenbach, MD, director of the department of vascular surgery and endovascular therapy at Augusta Krankenhaus hospital (Düsseldorf, Germany). “With the Enroute NPS we can leverage surgical principles of neuroprotection like avoiding unprotected maneuvers, maintaining exquisite control of the carotid bifurcation and blood flow, and removing embolic fragments of any size.”
“We have been working to improve the safety profile of carotid revascularization through the development of the TCAR procedure, and this latest design of the Enroute NPS for TCAR is state-of-the-art,” said Antonio Orgaz, MD, chief of vascular surgery at Virgen de la Salud Hospital (Toledo, Spain). “We were extremely impressed with the smooth, atraumatic entry of the sheath into the carotid artery and the more ergonomic design of the overall system. It is easy to use and inspires confidence.”
Patients are typically referred for a carotid stent when they have a blockage of 70% or more in the carotid artery and are unsuitable candidates for endarterectomy, a procedure that involves general anesthesia, which could be dangerous for people with severe carotid blockages since they often also have blockages in other arteries, including the coronary arteries.
Related Links:
Silk Road Medical
The Enroute NeuroProtection System (NPS) is designed to enable the insertion of a stent directly into the carotid artery in the neck, instead of using a percutaneous route through the groin and up the femoral artery, reducing the surgical risks and potential complications associated with more invasive procedures. In addition to TCAR access, the procedure also protects the brain during the intervention via flow reversal, a mechanism that redirects blood flow away from the brain so that it can carry any debris created to an external filter.
This high rate temporary blood flow reversal is important to help protect the brain from stroke while surgeons subsequently deliver the Enroute Transcarotid Stent (TNS), a self-expanding stent made of nickel-titanium (nitinol) alloy tubing, which is laser-cut into a mesh shape that opens automatically over the blockage. The Enroute NPS and TNS are products of Silk Road Medical (Sunnyvale, CA, USA), and have been approved by the US Food and Drug Administration (FDA).
“Whereas elsewhere in the body we routinely use minimally invasive endovascular techniques to treat vascular disorders, carotid artery disease is one of the last frontiers that is still treated primarily by an invasive surgical approach,” said Professor Ralf Kolvenbach, MD, director of the department of vascular surgery and endovascular therapy at Augusta Krankenhaus hospital (Düsseldorf, Germany). “With the Enroute NPS we can leverage surgical principles of neuroprotection like avoiding unprotected maneuvers, maintaining exquisite control of the carotid bifurcation and blood flow, and removing embolic fragments of any size.”
“We have been working to improve the safety profile of carotid revascularization through the development of the TCAR procedure, and this latest design of the Enroute NPS for TCAR is state-of-the-art,” said Antonio Orgaz, MD, chief of vascular surgery at Virgen de la Salud Hospital (Toledo, Spain). “We were extremely impressed with the smooth, atraumatic entry of the sheath into the carotid artery and the more ergonomic design of the overall system. It is easy to use and inspires confidence.”
Patients are typically referred for a carotid stent when they have a blockage of 70% or more in the carotid artery and are unsuitable candidates for endarterectomy, a procedure that involves general anesthesia, which could be dangerous for people with severe carotid blockages since they often also have blockages in other arteries, including the coronary arteries.
Related Links:
Silk Road Medical
Latest Surgical Techniques News
- Bioprinted Aortas Offer New Hope for Vascular Repair
- Early TAVR Intervention Reduces Cardiovascular Events in Asymptomatic Aortic Stenosis Patients
- New Procedure Found Safe and Effective for Patients Undergoing Transcatheter Mitral Valve Replacement
- No-Touch Vein Harvesting Reduces Graft Failure Risk for Heart Bypass Patients
- DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment
- Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
- Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
- World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
- AI-Generated Synthetic Scarred Hearts Aid Atrial Fibrillation Treatment
- New Class of Bioadhesives to Connect Human Tissues to Long-Term Medical Implants
- New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation
- Minimally Invasive Valve Repair Reduces Hospitalizations in Severe Tricuspid Regurgitation Patients
- Tiny Robotic Tools Powered by Magnetic Fields to Enable Minimally Invasive Brain Surgery
- Magnetic Tweezers Make Robotic Surgery Safer and More Precise
- AI-Powered Surgical Planning Tool Improves Pre-Op Planning
- Novel Sensing System Restores Missing Sense of Touch in Minimally Invasive Surgery
Channels
Critical Care
view channel
Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis
Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more
AI Interpretability Tool for Photographed ECG Images Offers Pixel-Level Precision
The electrocardiogram (ECG) is a crucial diagnostic tool in modern medicine, used to detect heart conditions such as arrhythmias and structural abnormalities. Every year, millions of ECGs are performed... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more